Table 5.
Sex Specific Age-Standardized Prevalence Rate of HF Based on Underlying Disease
| Global | Male | Female | |
|---|---|---|---|
| All causes | 831.0 (738.6 to 926.2) | 844.6 (752.5 to 936.0) | 817.5 (724.4 to 916.0) |
| Ischemic heart disease | 220.1 (187.8 to 255.8) | 259.7 (221.7 to 302.5) | 186.3 (158.3 to 218.5) |
| Hypertensive heart disease | 217.9 (184.1 to 254.1) | 172.3 (145.8 to 201.5) | 255.0 (216.5 to 296.9) |
| Chronic obstructive pulmonary disease | 194.5 (159.2 to 230.8) | 208.5 (170.0 to 248.5) | 182.6 (149.7 to 218.7) |
| Other cardiomyopathy | 53.9 (46.7 to 62.1) | 53.1 (45.9 to 61.2) | 54.5 (47.1 to 62.6 |
| Non-rheumatic degenerative mitral valve disease | 22.8 (14.7 to 32.6) | 22.1 (14.5 to 31.8) | 23.4 (15.1 to 33.8) |
| Other cardiovascular and circulatory diseases | 20.3 (16.6 to 24.3) | 22.9 (18.8 to 27.6) | 18.0 (14.8 to 21.7) |
| Alcoholic cardiomyopathy | 19.9 (16.8 to 23.3) | 27.7 (23.4 to 32.4) | 12.6 (10.6 to 14.7) |
| NonOrheumatic calcific aortic valve disease | 18.9 (12.2 to 27.5) | 20.4 (13.0 to 29.6) | 17.7 (11.3 to 26.3) |
| Other cardiovascular and circulatory diseases | 20.3 (16.6 to 24.3) | 22.9 (18.8 to 27.6) | 18.0 (14.8 to 21.7) |
| Rheumatic heart disease | 14.9 (12.6 to 17.4) | 11.0 (9.3 to 12.8) | 18.4 (15.5 to 21.6) |
| Myocarditis | 13.7 (11.8 to 15.8) | 11.4 (9.7 to 13.1) | 15.9 (13.6 to 18.2) |
| Congenital heart anomalies | 7.5 (5.9 to 9.5) | 7.8 (6.0 to 9.8) | 7.3 (5.7 to 9.2) |
| Endocarditis | 7.4 (6.3 to 8.5) | 6.8 (5.8 to 7.9) | 7.8 (6.6 to 9.1) |
| Interstitial lung disease and pulmonary sarcoidosis | 5.4 (4.1 to 6.5) | 5.9 (4.5 to 7.3) | 5.0 (3.9 to 6.0) |
| Endocrine, metabolic, blood, and immune disorders | 5.1 (4.2 to 6.1) | 4.9 (4.1 to 5.8) | 5.2 (4.3 to 6.3) |
| Other hemoglobinopathies and hemolytic anemias | 4.2 (3.4 to 5.0) | 3.8 (3.1 to 4.7) | 4.6 (3.8 to 5.5) |
| Chagas disease | 3.7 (2.4 to 5.3) | 4.8 (3.4 to 6.4) | 2.7 (1.6 to 4.2) |
| Other non-rheumatic valve diseases | 0.350 (0.287 to 0.421) | 0.291 (0.239 to 0.347) | 0.394 (0.322 to 0.476) |
| G6PD deficiency | 0.249 (0.206 to 0.301) | 0.346 (0.283 to 0.420) | 0.162 (0.133 to 0.195) |
| Silicosis | 0.140 (0.116 to 0.168) | 0.305 (0.252 to 0.363) | 0.006 (0.005 to 0.008) |
| Coal workers pneumoconiosis | 0.089 (0.075 to 0.104) | 0.186 (0.157 to 0.217) | 0.010 (0.008 to 0.011) |
| Asbestosis | 0.073 (0.061 to 0.086) | 0.141 (0.117 to 0.165) | 0.024 (0.019 to 0.029) |
| Other pneumoconiosis | 0.053 (0.045 to 0.062) | 0.093 (0.079 to 0.109) | 0.021 (0.017 to 0.025) |
| Thalassemias | 0.050 (0.039 to 0.063) | 0.050 (0.039 to 0.063) | 0.049 (0.036to 0.064) |
G6PD = Glucose-6-phosphate dehydrogenase
65.
Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of Heart Failure and Underlying Causes In 195 Countries and Territories from 1990 to 2017. Eur J Prev Cardiol. 2021 Dec 29;28(15):1682–90.